BRIEF-Zealand Pharma says diabetes drug Lyxumia approved in Europe

Mon Feb 4, 2013 2:08am EST

Related Topics

Feb 4 (Reuters) - Zealand Pharma A/S : * Announces once-daily lyxumia (lixisenatide) approved in Europe for the

treatment of type 2 diabetes * Under the agreement with Sanofi, the company is entitled to tiered low double-digit percentage royalties on global sales of Lyxumia


After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.